Dear Colleagues,
It has been an incredible 8 years of journey with MedGenome and I am grateful to my colleagues and team mates who have been part of this journey with me. Over the last few years, we have expanded the organisation manifolds with respect to clients, customers, team, technology and various associations and tie ups.
Even amidst the pandemic, it was due to our commitment, quality, and knowledge, that we were able to secure generous funding. We even initiated strategic tie ups in the infectious disease segment such as Covid-19 and TB to fight the battle against these diseases. We also have been part of many intriguing researches including the latest being use of Polygenic Risk Score technique for diagnosing cardiac diseases, which received international recognition.